In conclusion, our meta-analysis demonstrated the beneficial effect of ALA supplementation on reducing CRP, TNF-α, SBP, and TG in individuals with obesity or overweight. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.